James Molloy
Stock Analyst at Alliance Global Partners
(0.33)
# 4,156
Out of 4,896 analysts
32
Total ratings
17.65%
Success rate
-45.79%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGC IGC Pharma | Reiterates: Buy | $3.5 | $0.38 | +819.12% | 2 | Mar 6, 2025 | |
| INTS Intensity Therapeutics | Initiates: Buy | $8.5 | $0.33 | +2,452.55% | 1 | Jan 13, 2025 | |
| VTVT vTv Therapeutics | Initiates: Buy | $35 | $17.01 | +105.76% | 1 | Dec 9, 2024 | |
| GOVX GeoVax Labs | Initiates: Buy | $15 | $0.68 | +2,119.92% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $2.31 | +765.80% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $490 | $6.46 | +7,491.01% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $600 → $1,100 | $40.87 | +2,591.46% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.63 | +180.00% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $2.99 | +234.45% | 1 | Jul 17, 2024 | |
| XRTX XORTX Therapeutics | Maintains: Buy | $9 → $14 | $0.96 | +1,362.14% | 2 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $1.21 | +2,378.52% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $2.07 | +262.32% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.74 | +248.43% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.84 | +334.78% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $4.01 | +74.56% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.13 | +6,979.65% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $0.39 | +3,989.98% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $0.47 | +2,859.83% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.61 | +2,378.93% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,400 | $8.89 | +94,388.19% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $2.11 | +7,009.00% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $938 | $1.31 | +71,464.89% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $2.32 | +977.59% | 1 | Oct 4, 2021 |
IGC Pharma
Mar 6, 2025
Reiterates: Buy
Price Target: $3.5
Current: $0.38
Upside: +819.12%
Intensity Therapeutics
Jan 13, 2025
Initiates: Buy
Price Target: $8.5
Current: $0.33
Upside: +2,452.55%
vTv Therapeutics
Dec 9, 2024
Initiates: Buy
Price Target: $35
Current: $17.01
Upside: +105.76%
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $0.68
Upside: +2,119.92%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $2.31
Upside: +765.80%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $490
Current: $6.46
Upside: +7,491.01%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $600 → $1,100
Current: $40.87
Upside: +2,591.46%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.63
Upside: +180.00%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $2.99
Upside: +234.45%
XORTX Therapeutics
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $0.96
Upside: +1,362.14%
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.21
Upside: +2,378.52%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $2.07
Upside: +262.32%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.74
Upside: +248.43%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.84
Upside: +334.78%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $4.01
Upside: +74.56%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.13
Upside: +6,979.65%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $0.39
Upside: +3,989.98%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $0.47
Upside: +2,859.83%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.61
Upside: +2,378.93%
Sep 7, 2022
Initiates: Buy
Price Target: $8,400
Current: $8.89
Upside: +94,388.19%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $2.11
Upside: +7,009.00%
Jun 1, 2022
Initiates: Buy
Price Target: $938
Current: $1.31
Upside: +71,464.89%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $2.32
Upside: +977.59%